Cargando…

Early activation of the cardiac CX3CL1/CX3CR1 axis delays β-adrenergic-induced heart failure

We recently highlighted a novel potential protective paracrine role of cardiac myeloid CD11b/c cells improving resistance of adult hypertrophied cardiomyocytes to oxidative stress and potentially delaying evolution towards heart failure (HF) in response to early β-adrenergic stimulation. Here we cha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flamant, M., Mougenot, N., Balse, E., Le Fèvre, L., Atassi, F., Gautier, E. L., Le Goff, W., Keck, M., Nadaud, S., Combadière, C., Boissonnas, A., Pavoine, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429682/ https://www.ncbi.nlm.nih.gov/pubmed/34504250 http://dx.doi.org/10.1038/s41598-021-97493-z

Ejemplares similares

Revising CX3CR1 Expression on Murine Classical and Non-classical Monocytes
por: Meghraoui-Kheddar, Aïda, et al.
Publicado: (2020)

Transcriptomic and Lipidomic Mapping of Macrophages in the Hub of Chronic Beta-Adrenergic-Stimulation Unravels Hypertrophy-, Proliferation-, and Lipid Metabolism-Related Genes as Novel Potential Markers of Early Hypertrophy or Heart Failure
por: Nadaud, Sophie, et al.
Publicado: (2022)

Modulating neurotoxicity through CX3CL1/CX3CR1 signaling
por: Limatola, Cristina, et al.
Publicado: (2014)

The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
por: Pawelec, Paulina, et al.
Publicado: (2020)

CCL2/CCR2 and CX3CL1/CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration
por: Raoul, William, et al.
Publicado: (2010)

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection
por: Chen, Peiqing, et al.
Publicado: (2016)

Role of CX3CL1/CX3CR1 Signaling Axis Activity in Osteoporosis
por: Wojdasiewicz, Piotr, et al.
Publicado: (2019)

Involvement of CX3CL1/CX3CR1 Signaling in Spinal Long Term Potentiation
por: Bian, Chao, et al.
Publicado: (2015)

Regulation and function of CX3CR1 and its ligand CX3CL1 in kidney disease
por: von Vietinghoff, Sibylle, et al.
Publicado: (2021)

Hydrogen Sulfide Inhibits the Development of Atherosclerosis with Suppressing CX3CR1 and CX3CL1 Expression
por: Zhang, Huili, et al.
Publicado: (2012)

CX3CL1/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe?
por: Zhuang, Quan, et al.
Publicado: (2017)

CX3CL1–CX3CR1 Axis: A New Player in Coeliac Disease Pathogenesis
por: Fernández-Prieto, Marta, et al.
Publicado: (2019)

The Chemokine CX3CL1 (Fractalkine) and its Receptor CX3CR1: Occurrence and Potential Role in Osteoarthritis
por: Wojdasiewicz, Piotr, et al.
Publicado: (2014)

Involvement of CX3CL1/CX3CR1 axis in etanercept therapy for patients with active rheumatoid arthritis
por: Sato, Michihito, et al.
Publicado: (2011)

Therapeutic intervention of inflammatory/immune diseases by inhibition of the fractalkine (CX3CL1)-CX3CR1 pathway
por: Imai, Toshio, et al.
Publicado: (2016)

Microglia and Aging: The Role of the TREM2–DAP12 and CX3CL1-CX3CR1 Axes
por: Mecca, Carmen, et al.
Publicado: (2018)

Prevention of lipopolysaccharide-induced preterm labor by the lack of CX3CL1-CX3CR1 interaction in mice
por: Mizoguchi, Mika, et al.
Publicado: (2018)

Fractalkine Signalling (CX(3)CL1/CX(3)CR1 Axis) as an Emerging Target in Coronary Artery Disease
por: Loh, Shu Xian, et al.
Publicado: (2023)

CX3CR1 deficiency promotes muscle repair and regeneration by enhancing macrophage ApoE production
por: Arnold, Ludovic, et al.
Publicado: (2015)

CX(3)CR1 Is Expressed by Human B Lymphocytes and Meditates CX(3)CL1 Driven Chemotaxis of Tonsil Centrocytes
por: Corcione, Anna, et al.
Publicado: (2009)

Fractalkine (CX3CL1) and Its Receptor CX3CR1 May Contribute to Increased Angiogenesis in Diabetic Placenta
por: Szukiewicz, Dariusz, et al.
Publicado: (2013)

Repopulating retinal microglia restore endogenous organization and function under CX3CL1-CX3CR1 regulation
por: Zhang, Yikui, et al.
Publicado: (2018)

CX3CL1 and CX3CR1 could be a relevant molecular axis in the pathophysiology of idiopathic pulmonary fibrosis
por: Rivas-Fuentes, Selma, et al.
Publicado: (2020)

Tenophages: a novel macrophage-like tendon cell population expressing CX3CL1 and CX3CR1
por: Lehner, Christine, et al.
Publicado: (2019)

Cochlear resident macrophage mediates development of ribbon synapses via CX3CR1/CX3CL1 axis
por: Song, Xinyu, et al.
Publicado: (2022)

Correction: CX(3)CR1 Is Expressed by Human B Lymphocytes and Mediates CX(3)CL1 Driven Chemotaxis of Tonsil Centrocytes
por: Corcione, Anna, et al.
Publicado: (2010)

CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine/Chemokine Receptor Complex in Patients with AMD
por: Falk, Mads Krüger, et al.
Publicado: (2014)

CX(3)CR1-CX(3)CL1-dependent cell-to-cell Japanese encephalitis virus transmission by human microglial cells
por: Lannes, Nils, et al.
Publicado: (2019)

Comparative Analysis of the Occurrence and Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Hemophilic Arthropathy and Osteoarthritis
por: Wojdasiewicz, Piotr, et al.
Publicado: (2020)

Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?
por: Cormican, Sarah, et al.
Publicado: (2021)

Microglial CX(3)CR1 promotes adult neurogenesis by inhibiting Sirt 1/p65 signaling independent of CX(3)CL1
por: Sellner, Sabine, et al.
Publicado: (2016)

CX3CL1/CX3CR1 signal mediates M1-type microglia and accelerates high-altitude-induced forgetting
por: Wang, Xueting, et al.
Publicado: (2023)

The deficiency of CX3CL1/CX3CR1 system ameliorates high fructose diet-induced kidney injury by regulating NF-κB pathways in CX3CR1-knock out mice
por: Yu, Yong-Wu, et al.
Publicado: (2018)

Dynamic changes of CX3CL1/CX3CR1 axis during microglial activation and motor neuron loss in the spinal cord of ALS mouse model
por: Zhang, Jingjing, et al.
Publicado: (2018)

The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy
por: Chaudhri, Apoorvi, et al.
Publicado: (2023)

EHMTI-0062. Expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the trigeminal ganglia: implications for craniofacial nociception
por: Gazerani, P, et al.
Publicado: (2014)

High Glucose Level Disturbs the Resveratrol-Evoked Curtailment of CX3CL1/CX3CR1 Signaling in Human Placental Circulation
por: Szukiewicz, Dariusz, et al.
Publicado: (2017)

Corrigendum to “Comparative Analysis of the Occurrence and Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Hemophilic Arthropathy and Osteoarthritis”
por: Wojdasiewicz, Piotr, et al.
Publicado: (2020)

Regulation and biological functions of the CX3CL1-CX3CR1 axis and its relevance in solid cancer: A mini-review
por: Rivas-Fuentes, Selma, et al.
Publicado: (2021)

Diet-Induced Obesity Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma via CX3CL1/CX3CR1 Axis
por: Sun, Yue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v2kjntrcpigg53j1olla8ak3d4